You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent hematologic tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Hematologic Diseases
  • allogeneic γ9δ2 T Cells
  • +3 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 23, 2023

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

Recruiting
  • 19 and 22+ B Cell Hematologic Tumors
  • 19 and 20+ B Cell Hematologic Tumors
  • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
  • Wuhan, Hubei, China
    Tongji Hospital
Jan 11, 2023

SARS-CoV-2 Infection in Hematologic Tumors

Active, not recruiting
  • SARS-CoV-2 Infection
  • Hematologic Malignancy
  • None intervention
  • Beijing, Beijing, China
    Peking University First Hospital
Jan 13, 2023

Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

Recruiting
  • Hematological Malignancy
  • Cancer-Related Anemia
  • Shengxuening Tablet
  • Ferrous succinate
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Mar 13, 2023

Gastrointestinal Tumors Trial in Zhengzhou (First dose, Second dose, The third dose)

Recruiting
  • Gastrointestinal Tumors
  • First dose
  • +3 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Nov 22, 2023

Glioblastoma Trial in Rochester (WSD0628)

Not yet recruiting
  • Glioblastoma
  • Rochester, Minnesota
    Mayo Clinic
Jun 15, 2023

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Solid Tumors, Adult Trial in Xuzhou (TIL injection)

Recruiting
  • Solid Tumors, Adult
  • TIL injection
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital Of Xuzhou Medical University
Oct 12, 2023

Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

Recruiting
  • Colon Cancer
  • Chimeric antigen receptor T cell preparation targeting GCC
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
May 16, 2023

Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

Recruiting
  • Hematologic Malignancies
  • RD13-02 cell infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 26, 2023

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • Pavia, Italy
  • +2 more
Jul 10, 2022

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Adult Trial in Zhengzhou (GT101)

Recruiting
  • Adult
  • GT101
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 11, 2023

Gastrointestinal Cancer Trial in Xuzhou (BGT007 Injection)

Recruiting
  • Gastrointestinal Cancer
  • BGT007 Injection
  • Xuzhou, JangSu, China
    he Affiliated Hospital of Xuzhou Medical University
Oct 23, 2023

Solid Tumors, Adult Trial (tumor treatment vaccine injection)

Not yet recruiting
  • Solid Tumors, Adult
  • tumor treatment vaccine injection
  • (no location specified)
Feb 16, 2023

Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Gynecological Malignant Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Apr 9, 2023

Digestive Tract Cancer Trial in Xuzhou (BGT007H Injection)

Recruiting
  • Digestive Tract Cancer
  • BGT007H Injection
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Oct 23, 2023

Solid Tumor, Adult, Solid Tumor, Childhood, Hematologic Cancer Trial in Villejuif (Tumor biopsy, Blood sample, Bone marrow

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Tumor biopsy
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy Cancer Campus Grand Paris
Jul 28, 2022

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

Not yet recruiting
  • Pediatric Brain Tumor
  • +2 more
  • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
  • Implantation
  • San Francisco, California
    University of California, San Francisco
May 24, 2023

Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 14, 2023

Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

Not yet recruiting
  • Neuroblastoma
  • Solid Tumor
  • (no location specified)
Jan 18, 2023

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +5 more
    • (no location specified)
    Apr 8, 2023